glp 1 fda approval The just approved the first oral GLP-1 for obesity. Here's what it means. The facts: → Clinical trials demonstrate approximately 14% average weight loss—comparable to injectable formulations. → The starting dose New GLP-1 Pill Foundayo (Orforglipron)

Evens Skin Tone: Niacinamide 5% prevents melanin from reaching the skins surface, helping to unify the complexion and reduce contrast between dark and light areas

Better Blood Flow and Tissue Repair BPC 157 may help improve circulation, which is essential for healing

However, benzyl alcohol isnt safe for all patients

This depends on the severity of symptoms, B12 levels, and overall health

Here's why: People taking GLP-1s who drop a significant amount of weight are at risk of losing muscle as well as fat

Int J Obes , 2024, DOI: 10.1038/s41366-024-01526-2, Written by Tarun Sai Lomte Tarun is a writer based in Hyderabad, India